Xenetic Biosciences (XBIO) Short Interest Ratio & Short Volume $3.66 +0.01 (+0.27%) (As of 11/14/2024 ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsSEC FilingsShort InterestTrends Xenetic Biosciences Short Interest DataXenetic Biosciences (XBIO) has a short interest of 14,800 shares, representing 1.18% of the float (the number of shares available for trading by the public). This marks a -11.90% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.7, indicating that it would take 0.7 days of the average trading volume of 11,249 shares to cover all short positions.Current Short Interest14,800 sharesPrevious Short Interest16,800 sharesChange Vs. Previous Month-11.90%Dollar Volume Sold Short$60,532.00Short Interest Ratio0.7 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares1,542,000 sharesFloat Size1,250,000 sharesShort Percent of Float1.18%Today's Trading Volume15,791 sharesAverage Trading Volume11,249 sharesToday's Volume Vs. Average140% Short Selling Xenetic Biosciences? Sign up to receive the latest short interest report for Xenetic Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartXBIO Short Interest Over TimeXBIO Days to Cover Over TimeXBIO Percentage of Float Shorted Over Time Ad Porter & CompanyWatch this before it gets removed If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. Xenetic Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202414,800 shares $60,532.00 -11.9%1.2%0.7 $4.09 10/15/202416,800 shares $63,672.00 +460.0%1.3%1 $3.79 9/30/20243,000 shares $12,960.00 -50.0%0.2%0.2 $4.32 9/15/20246,000 shares $23,944.80 +9.1%0.5%0.5 $3.99 8/31/20245,500 shares $22,495.00 -71.7%0.4%0.4 $4.09 8/15/202419,400 shares $61,110.00 -11.4%1.6%1.6 $3.15 Get the Latest News and Ratings for XBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xenetic Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/31/202421,900 shares $93,951.00 +3,550.0%1.8%2.8 $4.29 7/15/2024600 shares $2,580.00 -93.0%0.1%0.1 $4.30 6/30/20248,600 shares $35,002.00 -18.1%0.7%2 $4.07 6/15/202410,500 shares $40,527.90 -11.0%0.8%2.1 $3.86 5/31/202411,800 shares $46,020.00 +210.5%0.9%2.2 $3.90 5/15/20243,800 shares $15,031.28 -39.7%0.3%0.6 $3.96 4/30/20246,300 shares $27,090.00 +125.0%0.5%1.1 $4.30 4/15/20242,800 shares $11,592.00 +64.7%0.2%0.5 $4.14 3/31/20241,700 shares $6,409.00 -22.7%0.1%0.3 $3.77 3/15/20242,200 shares $9,570.00 -74.7%0.2%0.4 $4.35 2/29/20248,700 shares $36,018.00 -20.9%0.7%1.6 $4.14 2/15/202411,000 shares $39,160.00 +0.9%0.9%2.2 $3.56 1/31/202410,900 shares $40,875.00 -35.9%0.9%2.1 $3.75 1/15/202417,000 shares $65,280.00 +71.7%1.4%3.6 $3.84 12/31/20239,900 shares $34,155.99 No Change0.8%2.3 $3.45 12/15/20239,900 shares $35,244.00 -10.8%0.8%2.4 $3.56 11/30/202311,100 shares $36,352.50 +7.8%0.9%1.9 $3.28 11/15/202310,300 shares $31,930.00 No Change0.8%1.3 $3.10 10/31/202310,300 shares $31,724.00 +17.1%0.8%1.2 $3.08 10/15/20238,800 shares $37,290.88 +3.5%0.7%1 $4.24 9/30/20238,500 shares $41,650.00 -48.2%0.6%0.5 $4.90 9/15/202316,400 shares $85,772.00 +127.8%1.2%1 $5.23 8/31/20237,200 shares $28,872.00 +67.4%0.6%0.4 $4.01 8/15/20234,300 shares $16,254.00 -39.4%0.3%0.2 $3.78 7/31/20237,100 shares $27,619.00 -78.3%0.5%0.2 $3.89 7/15/202332,700 shares $119,028.00 +52.8%2.5%1 $3.64 6/30/202321,400 shares $67,624.00 -18.6%1.6%0.7 $3.16 6/15/202326,300 shares $83,897.00 -15.2%2.0%1.1 $3.19 5/31/202331,000 shares $92,535.00 +3,775.0%2.4%1.3 $2.99 5/15/2023800 shares $0.00 -77.8%0.1%0 $0.00 4/30/202335,700 shares $14,994.00 -18.7%N/A1 $0.42 4/15/202343,900 shares $20,852.50 -11.7%N/A0.9 $0.48 3/31/202349,700 shares $20,178.20 +24.3%N/A0.9 $0.41 3/15/202340,000 shares $15,600.00 +58.1%N/A0.6 $0.39Bill Gates’s Next Big AI Bet: Stargate (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate 2/28/202325,300 shares $13,156.00 -34.6%N/A0.4 $0.52 2/15/202338,700 shares $22,446.00 -61.2%N/A0.5 $0.58 1/31/202399,800 shares $71,885.94 +130.0%N/A1.3 $0.72 1/15/202343,400 shares $16,492.00 +126.0%N/A0.6 $0.38 12/30/202219,200 shares $5,473.92 -31.9%N/A0.3 $0.29 12/15/202228,200 shares $10,152.00 +3.3%N/A0.5 $0.36 11/30/202227,300 shares $12,012.00 +264.0%N/A0.6 $0.44 11/15/20227,500 shares $3,188.25 +1.4%N/A0.2 $0.43 10/31/20227,400 shares $3,469.86 -70.3%N/A0.2 $0.47 10/15/202224,900 shares $13,570.50 -22.9%0.7%0.5 $0.55 9/30/202232,300 shares $17,348.33 +74.6%1.0%0.7 $0.54 9/15/202218,500 shares $13,366.25 -66.4%0.6%0.4 $0.72 8/31/202255,000 shares $41,800.00 -6.8%1.6%1.2 $0.76 8/15/202259,000 shares $54,280.00 -23.9%1.8%1.2 $0.92 7/31/202277,500 shares $70,323.50 -37.2%2.3%1.3 $0.91 7/15/2022123,300 shares $113,066.10 -11.8%3.7%0.9 $0.92 6/30/2022139,800 shares $111,979.80 +5.6%4.1%0.8 $0.80 6/15/2022132,400 shares $90,018.76 -22.2%3.9%0.8 $0.68 5/31/2022170,200 shares $135,309.00 -13.0%N/A0.9 $0.80 5/15/2022195,600 shares $129,096.00 -51.9%N/A1 $0.66 4/30/2022406,900 shares $302,530.15 +449.1%N/A2 $0.74 4/15/202274,100 shares $82,251.00 +160.9%N/A0.5 $1.11 3/31/202228,400 shares $28,968.00 -47.2%N/A0.2 $1.02 3/15/202253,800 shares $47,882.00 -43.9%N/A0.4 $0.89 2/28/202295,900 shares $91,124.18 +39.2%N/A0.6 $0.95 2/15/202268,900 shares $66,695.20 -5.0%N/A0.4 $0.97 1/31/202272,500 shares $73,950.00 -18.0%N/A0.3 $1.02 1/15/202288,400 shares $109,616.00 -36.9%N/A0.4 $1.24 12/31/2021140,000 shares $180,600.00 +263.6%N/A0.5 $1.29 12/15/202138,500 shares $54,670.00 -59.6%N/A0.1 $1.42 11/30/202195,400 shares $135,468.00 +32.9%N/A0.2 $1.42 11/15/202171,800 shares $122,060.00 +70.1%N/A0.1 $1.70 10/29/202142,200 shares $70,474.00 -6.0%N/A0 $1.67 10/15/202144,900 shares $80,820.00 +5.2%N/A0 $1.80 9/30/202142,700 shares $87,535.00 +85.7%N/A0 $2.05 9/15/202123,000 shares $54,740.00 -83.6%N/A0 $2.38 8/31/2021140,200 shares $417,796.00 -71.8%N/A0 $2.98 8/13/2021496,700 shares $1.71 million -69.0%N/A0.1 $3.45 7/30/20211,600,000 shares $6.51 million +313.0%20.0%0.2 $4.07 7/15/2021387,400 shares $747,682.00 +1,133.8%4.8%0.1 $1.93 6/30/202131,400 shares $64,056.00 -16.7%0.4%0.1 $2.04 6/15/202137,700 shares $84,071.00 -44.1%0.5%0.2 $2.23 5/28/202167,400 shares $128,734.00 -7.3%0.8%0.5 $1.91 5/14/202172,700 shares $114,139.00 +21.0%0.9%0.4 $1.57 4/30/202160,100 shares $123,205.00 -15.8%0.8%0.2 $2.05 4/15/202171,400 shares $156,366.00 -26.3%0.9%0.2 $2.19 3/31/202196,900 shares $196,707.00 -23.1%1.2%0.2 $2.03 3/15/2021126,000 shares $323,820.00 -8.3%1.6%0.2 $2.57 2/26/2021137,400 shares $372,354.00 -32.1%1.8%0 $2.71 2/12/2021202,300 shares $708,050.00 -15.4%2.6%0.1 $3.50Bill Gates’s Next Big AI Bet: Stargate (Ad)In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.I believe we are about to do it again with this new AI project called Stargate 1/29/2021239,000 shares $573,600.00 -30.7%3.1%0.1 $2.40 1/15/2021344,800 shares $993,024.00 -18.9%4.4%0.1 $2.88 12/31/2020425,100 shares $905,463.00 -19.5%5.7%0.1 $2.13 12/15/2020528,000 shares $1.06 million -4.6%7.1%0.2 $2.01 11/30/2020553,400 shares $558,934.00 -4.3%10.4%0.2 $1.01 10/30/2020587,500 shares $490,327.50 +18.2%11.0%2.5 $0.83 10/15/2020497,200 shares $462,246.84 +9.8%9.3%1.7 $0.93 9/30/2020452,700 shares $409,693.50 +15.5%8.5%0.9 $0.91 9/15/2020391,800 shares $354,774.90 -0.6%7.3%0.8 $0.91 8/31/2020394,100 shares $409,864.00 -4.1%7.4%0.7 $1.04 8/14/2020410,800 shares $488,852.00 +22.3%7.7%0.7 $1.19 7/31/2020335,900 shares $446,747.00 +1.1%6.3%0.5 $1.33 7/15/2020332,400 shares $332,400.00 -5.0%6.2%0.6 $1.00 6/30/2020349,900 shares $363,896.00 +13.8%6.6%1.1 $1.04 6/15/2020307,600 shares $321,442.00 +1.8%5.8%0.9 $1.05 5/29/2020302,300 shares $302,300.00 -7.1%5.7%1.3 $1.00 5/15/2020325,400 shares $291,135.38 -3.0%6.1%1.3 $0.89 4/30/2020335,400 shares $310,245.00 -3.9%6.3%1.4 $0.93 4/15/2020349,100 shares $286,157.27 +8.0%6.6%1.1 $0.82 3/31/2020323,200 shares $239,329.60 +0.5%6.1%0.8 $0.74 3/13/2020321,700 shares $241,275.00 +2.6%9.5%1.3 $0.75 2/28/2020313,700 shares $169,398.00 +52.4%9.3%0.6 $0.54 2/14/2020205,900 shares $162,661.00 +16.3%6.1%0.4 $0.79 1/31/2020177,000 shares $189,390.00 +21.7%5.2%0.3 $1.07 1/15/2020145,500 shares $190,605.00 -46.9%3.1%0.3 $1.31 12/31/2019273,900 shares $427,284.00 +1.8%5.8%0.4 $1.56 XBIO Short Interest - Frequently Asked Questions What is Xenetic Biosciences' current short interest? Short interest is the volume of Xenetic Biosciences shares that have been sold short but have not yet been closed out or covered. As of October 31st, traders have sold 14,800 shares of XBIO short. 1.18% of Xenetic Biosciences' shares are currently sold short. Learn More on Xenetic Biosciences' current short interest. What is a good short interest ratio for Xenetic Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XBIO shares currently have a short interest ratio of 1.0. Learn More on Xenetic Biosciences's short interest ratio. What is a good short interest percentage for Xenetic Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.18% of Xenetic Biosciences' floating shares are currently sold short. Is Xenetic Biosciences' short interest increasing or decreasing? Xenetic Biosciences saw a drop in short interest during the month of October. As of October 31st, there was short interest totaling 14,800 shares, a drop of 11.9% from the previous total of 16,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Xenetic Biosciences' float size? Xenetic Biosciences currently has issued a total of 1,542,000 shares. Some of Xenetic Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Xenetic Biosciences currently has a public float of 1,250,000 shares. How does Xenetic Biosciences' short interest compare to its competitors? 1.18% of Xenetic Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Xenetic Biosciences: CytoMed Therapeutics Limited (2.01%), Bolt Biotherapeutics, Inc. (0.26%), Lisata Therapeutics, Inc. (0.25%), MIRA Pharmaceuticals, Inc. (12.65%), BriaCell Therapeutics Corp. (2.34%), Unity Biotechnology, Inc. (1.97%), Spruce Biosciences, Inc. (0.56%), Pieris Pharmaceuticals, Inc. (1.70%), NeuroBo Pharmaceuticals, Inc. (0.64%), MEI Pharma, Inc. (1.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Xenetic Biosciences stock? Short selling XBIO is an investing strategy that aims to generate trading profit from Xenetic Biosciences as its price is falling. XBIO shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Xenetic Biosciences? A short squeeze for Xenetic Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XBIO, which in turn drives the price of the stock up even further. How often is Xenetic Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XBIO, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies CytoMed Therapeutics Short Squeeze Bolt Biotherapeutics Short Squeeze Lisata Therapeutics Short Squeeze MIRA Pharmaceuticals Short Squeeze BriaCell Therapeutics Short Squeeze Unity Biotechnology Short Squeeze Spruce Biosciences Short Squeeze Pieris Pharmaceuticals Short Squeeze NeuroBo Pharmaceuticals Short Squeeze MEI Pharma Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:XBIO) was last updated on 11/14/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredElon Musk’s $30 Billion Trump Bet Pays Off—What’s Next?Elon Musk bet big on Trump's victory, and that gamble has already added over $30 billion to his net worth in a...InvestorPlace | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredBreaking News: Are Trump/Musk Planning an AI Takeover? (Shocking)Now that he is Donald Trump’s right-hand man… You owe it to yourself to see Elon Musk’s big AI prediction f...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xenetic Biosciences Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Xenetic Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free XBIO Stock Alerts